INTERESTING EYE NEWS & CLINICAL PEARLS

 A large retrospective cohort study published in the British Journal of Ophthalmology suggests that long-term statin use may reduce both the risk of developing open-angle glaucoma (OAG) and the need for subsequent treatment escalation.  Key Findings Reduced Incidence: Statin users showed a 15% lower risk of developing OAG at 5 years and a 10% lower risk at 10 years. Lower Risk of Treatment Escalation: Among patients with existing OAG (n = 29,598 per group), 5-year statin use was associated with: 60% lower risk of selective laser trabeculoplasty (SLT) 55% lower risk of minimally invasive glaucoma surgery (MIGS) 36% lower risk of traditional incisional glaucoma surgery 11% lower risk of needing additional topical ocular hypotensive prescriptions Sustained Benefit: These protective associations persisted through 10 years of follow-up, though the magnitude of effect slightly decreased over time. Potential Mechanisms & Limitations Researchers suggest statins may benef...

A recent retrospective study published in the British Journal of Ophthalmology highlights an often-overlooked factor in glaucoma management: the weather. Researchers in Japan evaluated longitudinal data over an 11-year period for patients with stable primary open-angle glaucoma (POAG) who maintained a constant medication routine. Their findings revealed that ambient temperature is negatively correlated with intraocular pressure (IOP) —meaning as outdoor temperatures drop, eye pressure tends to rise. Key Takeaways from the Research: Temperature Influence: Ambient temperature showed a significant, independent negative contribution to IOP fluctuations. Other Contributing Factors: IOP was positively correlated with mean blood pressure and influenced by central corneal thickness, time of day (pressures were higher in late afternoon compared to morning), and the specific drop regimen. Greater Impact in Advanced Cases: The study noted that IOP responsiveness to temperature changes is part...